ALFA News
Straight from the exchange filing
Every announcement Zydus Lifesciences has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Zydus Lifesciences announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Zydus Lifesciences' Zylidac Bio partners with Prolific Machines to scale light-controlled biologics manufacturing. Latest quarterly revenue stands at ₹8,017 Cr.
Zydus Lifesciences receives USFDA approval for Estradiol and Levonorgestrel Transdermal System, targeting a USD 45.7 million US market with 180-day exclusivity.
Zydus Lifesciences launches REVAHALE, India's first once-daily nebulised LAMA for COPD, offering 24-hour relief. Company TTM revenue stands at 27,148.4 crores.
Zydus Lifesciences signs MoU with Apollo Hospitals to launch the Shield™ Multi-Cancer Detection test in India, targeting 10 cancer types via single blood draw.
